Risk factors for hepatocellular carcinoma (HCC) include hepatitis B and C viruses (HBV, HCV), excessive alcohol consumption, rare genetic disorders and diabetes / obesity. The population attributable fractions (PAF) of these factors, however, have not been investigated in population-based studies in the United States. Among individual factors, diabetes / obesity had the greatest PAF (36.6 % ), followed by alcoholrelated disorders (23.5 % ), HCV (22.4 % ), HBV (6.3 % ) and rare genetic disorders (3.2 % ). While diabetes / obesity had the greatest PAF among both males (36.4 % ) and females (36.7 % ), alcoholrelated disorders had the second greatest PAF among males (27.8 % ) and HCV the second greatest among females (28.1 % ). Diabetes / obesity had the greatest PAF among whites (38.9 % ) and Hispanics (38.1 % ), while HCV had the greatest PAF among Asians (35.4 % ) and blacks (34.9 % ). The second greatest PAF was alcohol-related disorders in whites (25.6 % ), Hispanics (30.1 % ) and blacks (and 18.5 % ) and HBV in Asians (28.5 % ).
INTRODUCTION
Primary liver cancer, of which hepatocellular carcinoma (HCC) is the most common histological type, is the sixth most frequently occurring cancer in the world, and the second most common cause of cancer mortality ( 1 ) . In the United States, the incidence of HCC has almost tripled over the past two decades, with ~ 20,000 individuals being newly diagnosed each year ( 2 ) . Well-established HCC risk factors include alcoholic liver disease, chronic infection with hepatitis B and / or C virus (HBV, HCV), and some rare autoimmune or genetic conditions such as autoimmune hepatitis, hereditary hemochromatosis, alpha-1 antitrypsin defi ciency, Wilson disease and some porphyrias ( 3 ) . In concert with the worldwide epidemics of obesity and type 2 diabetes mellitus, increasing evidence suggests a signifi cant contribution of these
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conditions to HCC risk ( 4 -6 ) . Recently, a large US study identifi ed metabolic syndrome, as well as its individual components (i.e., obesity, diabetes), as signifi cant risk factors for HCC ( 7 ) .
Th e distribution of HCC risk factors in any population may vary over time and in diff erent groups. In addition, estimates of relative risk or odds ratios (ORs) for any of the above HCC risk factors are not capable of describing their contribution to tumor incidence, as the latter is also driven by the prevalence of the factor in the general population. Better characterizations of the impact of the risk factors on the incidence of HCC are the population attributable fractions (PAF), which account both for the strength of the association between exposure and outcome, and also for the prevalence of the exposure in the population. Studies have reported PAFs for HCC in Italy ( 8 -10 ) , Europe ( 11 ) and worldwide ( 12 ) , but PAFs for the US have not been previously reported. Th erefore, the goal of the current study was to investigate the PAFs for HCC using data from the SEER-Medicare linked database.
METHODS
Data were obtained from the SEER-Medicare database, which is the linkage of cancer registry data from the National Cancer Institute ' s Surveillance, Epidemiology and End Results (SEER) program with Medicare medical claims data ( 13 ) . Th e SEER program began collating data on cancer cases in 1973, in the states of Connecticut, Iowa, New Mexico, Utah, and Hawaii and the metropolitan areas of Detroit and San Francisco-Oakland. In subsequent years, SEER was expanded to include registries in the Atlanta and Seattle-Puget Sound areas (1974 -1975) . SEER also provides assistance to the Alaska Native Tumor Registry. Th e data quality and completeness are ascertained regularly.
Medicare is the primary health insurer for ~ 97 % of individuals aged 65 years and older in the United States. Approximately 99 % of Medicare benefi ciaries are covered by Medicare part A benefi ts, which cover inpatient hospitalizations, and 95 % by part B benefi ts, which cover outpatient visits and supplier services. Th e linked SEER-Medicare data set contains part A and part B claims data beginning in 1991 for all Medicare-enrolled patients identifi ed by SEER registries . Th e linkage captures ~ 93 % of patients in the SEER database aged 65 years and older.
Cases
All persons diagnosed with HCC (ICD-O topography code = C22 and morphology codes = 8170 -8175) in a SEER registry who met the following criteria were eligible for inclusion as cases: diagnostic confi rmation of HCC, age 65 years or older at diagnosis, and enrolled in Medicare between 1991 and 2007. Diagnostic confi rmation was defi ned as having positive histology, cytology, laboratory test / marker study, direct visualization, or positive radiology tests. Individuals with clinical diagnosis only, unknown method of confi rmation, or HCC reported exclusively by death certifi cate or at autopsy were not eligible for inclusion. To include persons with equal exposure to risk factor information, all individuals had to have continuous enrollment in Medicare parts A and B for at least 3 years before HCC diagnosis. Th is criterion resulted in a minimum age of 68 years for all participants.
Persons enrolled in a health maintenance organization (HMO) were excluded because Medicare HMO plans have not been required to submit individual claims to CMS for specifi c services.
To avoid the inclusion of metastatic liver disease, all persons with prior diagnoses of stomach, colon, lung, pancreatic, breast, prostate or rectal cancers were excluded.
Controls
A 5 % random sample of Medicare benefi ciaries with no prior cancer diagnosis of HCC who resided in the geographic regions of the SEER-13 registries were selected as controls. Th e same inclusion / exclusion criteria as used for the cases were applied. A pseudodiagnosis date using a random number generator was assigned to controls. Controls were matched to cases on the year of search for risk factors to minimize possible diagnostic trends.
Risk factors of interest
Risk factors were identifi ed for a minimum of 3 years prior to HCC diagnosis or reference data for the comparison group. Th e ICD-9 codes used to identify the risk factors are shown in Supplementary Table 1 online. As presence of diabetes and obesity are highly correlated, these conditions were combined in the data analyses.
Th e study protocol was approved by the Offi ce of Human Subjects Research of the National Institutes of Health, Bethesda, MD.
Statistical analyses
Age, race / ethnicity (white, black, Hispanic, Asian, other), geographic region (SEER-13 registry region), and state buy-in status were included as covariates. Th e state buy-in variable indicates whether a third-party pays a benefi ciary ' s Medicare premiums, and was thus used as an indicator of lower socioeconomic status. Demographic features and pre-existing medical conditions were compared between cases and controls using t -tests for continuous variables and Chi-square or Fisher ' s exact tests for categorical variables. Logistic regression was used to calculate ORs and 95 % confi dence intervals (95 % CI). Wald χ 2 tests determined the signifi cance of variables in the logistic regressions. Adjusted PAFs for a specifi c risk factor or set of risk factors were computed using a method for estimating PAFs from population-based casecontrols studies with odd ratios for the risk factor set of risk factors adjusted for confounders and other risk factors ( 14, 15 ) . 95 % confi dence intervals were computed using s.e. estimates of adjusted PAFs ( 16 ) .
All tests of statistical signifi cance were two-sided and a P value < 0.05 was considered statistically signifi cant. Statistical analyses were performed using SAS Version 9.1 (SAS Institute, Cary, NC). In compliance with SEER-Medicare privacy standards, all cells with fewer than 11 individuals in any table are displayed as " < 11 " . Table 1 , 6,991 individuals with HCC and 255,702 control individuals were included in the analysis. Th e greatest percentage of persons with HCC were white (71 % ), followed by Asian (12 % ), black (8 % ), and Hispanic persons (4 % ). Th e majority of the cases (65.7 % ) were male; a proportion which did not vary greatly by racial / ethnic group.
RESULTS

As shown in
Overall, 22.9 % of the cases were positive for HCV, 6.9 % were positive for HBV, 31.2 % had prior alcohol-related liver disorders, 4.5 % had rare genetic disorders, 61.5 % had prior diagnoses of diabetes and / or obesity (hereaft er referred to as diabetes / obesity) and 19.1 % had no prior diagnosis of any of the above conditions ( Table 1 ). In contrast, 0.4 % of the controls were positive for HCV, 0.1 % were positive for HBV, 7.4 % had prior alcohol-related liver disorders, 0.8 % had rare genetic disorders, 34.7 % had a prior diagnosis of diabetes / obesity and 60.5 % had no prior diagnosis of any of the above conditions. Th e prevalence of almost all conditions varied greatly by racial / ethnic group. For HCV, the highest rate was found among Asians (cases = 37.1 % , controls = 1.7 % ) and the lowest rate, among white persons (cases = 18.5 % , controls = 0.4 % ). For HBV, the highest rate was again among Asians (cases = 30.3 % , controls = 1.5 % ) and the lowest rate among white persons (cases = 2.8 % , controls = 0.1 % ). For alcohol-related liver disorders, the highest percentage was seen among Hispanics (cases = 39.3 % , controls = 9.0 % ) and the lowest percentage was seen among Asians (cases = 21.9 % , controls = 4.5 % ). For rare genetic disorders, the highest percentage of aff ected persons occurred among white persons (cases = 5.0 % , controls = 0.7 % ) and the lowest percentage occurred among black persons (cases = < 2.1 % , controls = 0.8 % ). Diabetes was relatively common in all groups, with percentages ranging from 68.9 % of Hispanic cases and 50.7 % of Hispanic controls to 58.7 % of white cases and 31.0 % of white controls. Percentages of persons who were obese varied more widely, with Hispanics having the highest percentages (cases = 13.1 % , controls = 7.1 % ) and Asians having the lowest percentages (cases = 2.5 % , controls = 2.8 % ). When diabetes and obesity were grouped together, the percentage of aff ected persons ranged from 71.5 % of Hispanic cases and 52.4 % of Hispanic controls to 61.0 % of white cases and 32.8 % of white controls. Table 2 displays the OR of each risk factor overall and by gender. Among the total population, HCV had the largest OR at 39.9 (95 % CI = 36.3 -43.8), followed by HBV (OR = 11.17; 95 % CI = 9.18 -13.59), alcohol-related disorders (OR = 4.06, 95 % CI = 3.82 -4.32), rare genetic disorders (OR = 3.45, 95 % CI = 2.97 -4.02), and fi nally diabetes / obesity (OR = 2.47, 95 % CI = 2.34 -2.61). ORs were also calculated aft er eliminating all risk factors that arose in the 12 months preceding the diagnosis of HCC. No appreciable change was noted in this sensitivity analyis (data not shown).
Th e PAF of each factor is also shown in Table 2 . Overall, the greatest PAF was associated with diabetes / obesity (36.6 % ), followed by alcohol-related liver disorders (23.5 % ), HCV (22.4 % ), HBV (6.3 % ), and rare genetic disorders (3.2 % ). A comparison of PAFs in males and females found that the single greatest PAF in both genders was conferred by diabetes / obesity (male = 36.4 % , female = 36.7 % ). Among males, alcohol-related liver disorders had the second greatest PAF (27.8 % ), followed by HCV (19.3 % ). Among females, the order of alcohol-related liver disorders and HCV was reversed with HCV having a PAF of 28.1 % and alcoholrelated liver disorders having a PAF of 15.4 % . HBV had very similar PAFs in both genders (male = 6.4 % , female = 6.1 % ). In contrast, rare genetic disorders had a substantially larger role among males (4.3 % ) than among females (0.9 % ). All factors together accounted for a larger proportion of HCC in males (65.6 % ) than in females (62.2 % ).
An examination of PAFs by racial / ethnic group found noticeable diff erences among the groups ( Table 3 ) . Among white persons, the factor with the greatest PAF (38.9 % ) was diabetes / obesity, followed by alcohol-related liver disorders (25.6 % ) and HCV (18.1 % ). Among black persons, the factor with the greatest PAF was HCV (34.9 % ), followed by alcohol-related liver disorders (18.5 % ) and diabetes / obesity (11.5 % ). Among Hispanics, diabetes / obesity had the greatest PAF (38.1 % ) followed by alcohol-related liver disorders (30.1 % ) and HCV (28.2 % ), while among Asians, the factors with the greatest PAFs were HCV (35.4 % ), diabetes / obesity (28.5 % ) and HBV (28.5 % ). Th e cumulative PAF of these factors was highest among Asians (70.1 % ), followed by Hispanics (69.7 % ), white persons (64.0 % ) and fi nally, black persons (52.4 % ) .
A comparison by time period found that the PAFs of all factors increased in the interval between 1994 -1999 and 2000 -2007 ( Table 4 ) . Th e combined PAFs of all factors increased from 54.3 % in 1994 -1999 to 65.7 % in 2000 -2007. Th e PAFs of HCV and HBV increased most substantially, with the PAF of HCV increasing from 13.3 % to 25.3 % and the PAF of HBV increasing from 3.1 % to 7.2 % . Th e PAFs of the other factors increased more modestly, with the PAF of alcohol-related liver disorders increasing from 21.4 % to 23.0 % , rare genetic disorders from 2.6 % to 3.2 % and diabetes / obesity from 30.0 % to 35.6 % . Although diabetes can be an independent risk factor for HCC, it can at times, also be the result of another HCC risk factor. Th erefore, cumulative PAFs that did not include diabetes were also calculated for the two time periods of interest. For the period 1994 -1999, the cumulative PAF for all factors except diabetes / obesity was 34.9 % (31.9 -37.9 % ). In the time period 2000 -2007, the cumulative PAF for all risk factors except diabetes / obesity was 46.0 % (44.5 -47.5 % ) (data not shown).
DISCUSSION
Th is is the fi rst population-based case -control study to report PAFs for HCC risk factors in the United States. Th e estimate of the cumulative PAF for HBV, HCV, alcohol-related liver disease, diabetes / obesity and some rare genetic disorders indicated that these factors account for 64.5 % (males 65.6 % ; females 62.2 % ) of the HCC cases in this population. By race / ethnicity, the combined cumulative PAF was highest among Asians (70.1 % ) and lowest among black persons (52.4 % ).
Th e calculation of PAFs for the individual factors indicates that diabetes / obesity had the highest PAF for HCC in both the cumulative (36.6 % ) and gender-specifi c analyses (males 36.4 % ; females 36.7 % ). PAF estimates for these condition(s) also exceed those for any other HCC risk factor in white persons (38.9 % ) and Hispanics Alcohol-related liver disorders, well established to promote hepatocarcinogenesis ( 23 ) , had the second greatest PAF (23.5 % ) for HCC in the overall population and among males (27.8 % ). Among women, alcohol-related disorders ranked third (15.4 % ). Among racial / ethnic groups, alcohol-related disorders had the second greatest PAF among white persons (25.6 % ), Hispanics (30.1 % ), and black persons (18.5 % ), but had the fourth greatest PAF among Asians. Th e gender and racial / ethnic distributions of the PAFs are not unexpected in that they mirror the alcohol consumption patterns in the US population, where males are heavier alcohol consumers than females and Asians are the group least likely to consume any alcohol, or to be heavy drinkers ( 24 ) .
Th e PAF estimates for alcohol-related liver disorders are comparable to those described in a previous US single center study in which 32 % of the HCCs were attributable to daily alcohol consumption ( 25 ) , but lower than the PAFs in an Italian study, in which 45 % of the cancer cases were alcohol-related ( 9 ) . Th e current results are similar to a recent report from the EPIC study that reported PAFs for alcohol of 33 % among men and 18 % among women ( 26 ) .
While the ORs of HCC were far higher for HCV or HBV than for other conditions, the same was not true of their attributable fractions. Because chronic HCV and HBV infections are uncommon in the general population, the PAFs of HCV (22.4 % ) and HBV (6.3 % ) were only third and fourth highest overall. A greater proportion of HCC among women (28.1 % ) than men (19.3 % ), however, was attributable to HCV, while the proportions of HCC attributable to HBV were comparable between the genders. Th e higher PAF of HCV among women is not unanticipated as other risk factors, such as heavy alcohol consumption and rare genetic disorders, were much less common among women than men. As expected, high PAFs for both HCV and HBV infection were found among Asians. Th e high prevalence of these infections in Asians of ages 68 years and older may be due to immigration from Asian countries where these viruses are more prevalent ( 27, 28 ) . Th e high PAF for HCV among black persons (34.9 % ) is consistent with data (38.1 % ), and, together with HBV infection, had the second highest PAF among Asians (28.5 % ). Th is fi nding emphasizes that despite having the lowest relative risk among the factors examined, the high prevalence of diabetes / obesity in the study population translated into a high attributable fraction. Th e impact of non-alcoholic fatty liver disease (NAFLD) or non-alcoholic fatty steatohepatitis as the hepatic manifestation of diabetes / obesity has been clearly linked to liver disease progression (fi brosis, cirrhosis) and HCC risk in several clinical or molecular studies ( 17 -20 ) . Th e recent increase in diabetes, obesity and NAFLD and its impact on HCC incidence highlights the need for eff ective screening and prevention programs, and the development of strategies to halt liver disease progression in persons with NAFLD. In some instances, of course, diabetes may be the result of another HCC risk factor such as HCV or hemochromatosis ( 21 ) . As the Medicare data do not contain each person ' s complete medical history, it was not possible for the current study to determine whether diabetes resulted from another HCC risk factor or simply co-occurred with another factor. It was possible, however, to calculate the PAF of all factors except diabetes / obesity and to compare that result with the PAF of all factors including diabetes / obesity. In both time periods, the diff erence in PAF was between 19 % and 20 % , which represents the percentage of HCC accounted for by diabetes / obesity aft er all other risk factors have been eliminated.
Th e impact of obesity on HCC risk was previously assessed in a recent report from the European Prospective Investigation into Cancer (EPIC) cohort ( 11 ) . Adjusted relative risk estimates for obesity in the EPIC Study and obesity / diabetes in our study population were similar (OR 2.13 and 2.47, respectively). Diff erences in the PAF for obesity (16.1 % in EPIC) likely refl ects varying levels of obesity in the US and Europe, as a recent report found that the prevalence of obesity among US adults was 33.1 % , but only 17.1 % among European adults ( 22 ) . Th e same report also found a notable diff erence in the prevalence of diabetes in the US (16.4 % ) vs. Europe (10.9 % ) ( 22 ). Cumulative PAF for HBV, HCV, alcohol-related disease, rare metabolic disorder, diabetes and obesity adjusting for sex (except for male / female reates), race, age at dx .
LIVER
Attributable Risks for HCC relied on medical billing records for risk factor information. As a result, many of the medical conditions, in particular obesity, were underestimated. Medical conditions, such as HBV and HCV infection, which are determined by clinical tests, are likely to be more underestimated in controls than cases as the serological tests are not routinely run on all persons. Reliance on medical records data rather than questionnaire data also precluded obtaining more detailed information on behavioral risk factors such as the amount of alcohol consumed and tobacco-smoking patterns. For this reason, the assessment of attributable fractions for tobacco smoking was not possible, although liver cancer has now been included by IARC on the list of cancers causally associated with tobacco smoking ( 32 ) . Finally, combinations of ICD-9 codes used for risk factor identifi cation were not previously validated.
In conclusion, the results of this population-based study indicate that the dominant risk factors for HCC in the United States may diff er by sex and race / ethnicity. Overall, however, eliminating diabetes and obesity could have a larger eff ect on reducing the incidence of HCC than the elimination of any other risk factor.
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We thank Tim McNeel of Information Management Services, Inc for computer programming and data management support to the project. from the National Health and Nutrition Examination Survey that found higher prevalences of HCV infection among non-Hispanic black persons (4.1 % ) than among non-Hispanic white persons (3.0 % ) or among Mexican-Americans (3.4 % ) ( 29 ) .
CONFLICT OF INTEREST
Guarantor
Not unexpectedly given their low prevalence in the population, the PAF of rare genetic disorders combined was only 3.2 % , although there were diff erences by gender (males 4.3 % ; females 0.9 % ) and racial group (white persons 3.9 % ; Asians 1.9 % ). PAFs for rare genetic disorders could not be assessed in black persons or Hispanics due to the small number of HCC cases with these conditions. Similarly, the PAF of autoimmune hepatitis could not be assessed as there were no HCC cases with a prior diagnosis of autoimmune hepatitis, a fi nding consistent with the literature ( 30 ) .
Th e PAFs of HCV and HBV almost doubled between 1994 -1999 and 2000 -2007, while the PAFs of all other conditions increased less dramatically. Th e overall increases in PAFs suggest that better ascertainment of the studied conditions, as well as increased prevalence in the population or changes in the underlying population, could underlie the trends. Th e increasing PAF of HCV is almost certainly due to both its increased prevalence in the population and better ascertainment as screening for HCV infection was not available until the early 1990s. Th e increased prevalence of obesity and diabetes in the underlying population since the mid-1980 s has been well documented ( 31 ) .
Th e current study had notable strengths, as well as some limitations. A major strength was the source of the data. Th e SEERMedicare database is population based and covers a representative portion of the US population. As a result, the fi ndings of the current study should be generalizable to the US population aged 68 years and older. Th e SEER program maintains a case ascertainment completeness rate of at least 98 % , thus it is unlikely that the HCC cases in the current study are not representative of all HCC cases in this population. In addition, all diagnoses of HCC in the current study were confi rmed by pathology, radiology, and / or laboratory staging. Th e greatest limitation of the study is that it Cumulative PAF for HBV, HCV, alcohol-related disease, rare metabolic disorder, diabetes, and obesity adjusting for sex, race, age at dx.
